Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
about
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifeneThe evolution of selective estrogen receptor modulators in osteoporosis therapyThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceNew antiresorptive therapies for postmenopausal osteoporosisBreast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesTissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy.Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosisThe Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.The Tissue-Selective Estrogen Complex: A Review of Current EvidenceProfile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fractureManagement of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combinationEffects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeysThe tissue selective estrogen complex: a promising new menopausal therapyTissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells.Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate modelEndometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.Conjugated estrogens and bazedoxifeneBazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.SERMs and SERMs with estrogen for postmenopausal osteoporosis.Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.Advances in menopausal therapy: the tissue-selective estrogen complex.Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.Emerging hormonal treatments for menopausal symptoms.Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis.Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause.
P2860
Q26751149-BFFDC3FF-44B9-4182-9C09-118EE2D15396Q26827973-ABC45F21-5FDE-4F08-B9C9-9B0AC65D81B5Q26830744-589187E8-3BC5-40AD-8575-C8F3729D2C9FQ27014775-C01C5BA6-47B9-4C91-973E-DB444B5A6061Q30409045-B1FA79C1-EACA-4BBF-8A2A-956C2E991410Q30454254-4C7DE3A7-DCC6-4FAA-8697-D0D0D2F3B4D4Q30455905-5CA72270-286A-4BF1-99E8-EAD8D3846B4BQ30456770-274AC4A8-B573-4B54-BEB9-A9849A7D5364Q34315413-369EA9B3-0F3E-4398-8463-9E769BA02632Q35028647-A4E7DD6C-99BD-4507-86B1-008B2C542725Q35092811-7DF047F4-6C7E-433D-9046-F335CB9F1022Q35885187-ADB33982-7BA0-4BA8-976F-6BB80E7EBC3BQ35969254-876743D1-C58A-4BD6-ABD1-4A9B214A85FAQ36059535-5FDA87D6-1403-4AFC-8609-EE552EEB026BQ36432425-0136B8B1-B4D1-42CE-9B3C-89379439E90CQ36942968-8F1B0FCA-FDEC-46FA-8A09-3BA23402CD9FQ37048294-1FDB3FED-B793-4516-B997-E84B96997596Q37095740-E1849084-B089-4BDF-B637-1911FB1B9595Q37146858-F7124DF3-2EC8-44BE-8AB1-8778587DA6F9Q37277298-B293C7B0-D24E-4E9E-A55F-72BC441CF53AQ37304372-9E704755-E9DA-4D55-8E62-F5B03979094DQ37483322-13DB7ACE-1D63-460A-A391-3DFD279A1978Q37648048-006A1398-6490-4C05-8591-CFD290F0465FQ37676345-4D3EE02E-1FBE-480D-872E-2EFCF7478E28Q37698607-A80848D6-F9D4-413A-847D-94CAEA232789Q37743272-F418E64A-FEFB-4053-9B30-FFEB9ADB4799Q37808639-43AB1CC2-0D00-44AC-B606-DFA0F312EAB9Q38149162-85911281-F511-4AE7-BE91-E74C557C8386Q38161857-8188B3A9-F726-47CD-A174-1029AEF8DC30Q38192058-5EC5874B-1935-4B44-B28E-FBFDC8485BB7Q38307019-A6A4AA3B-D771-414F-9528-AC8E6788A94CQ38793387-50108D7A-08BC-42B0-8076-23BE19D0A976Q38993271-F595716D-9500-4993-8DC2-E15E51D17DE2Q39387047-485DAFF8-3D75-4287-B0F8-2E5B9E7AE03BQ41685808-C14121AC-0DA5-42C9-B4F2-DAE0351C4C4AQ43253442-54300F52-ECB9-440B-93F7-F1967BE2EADDQ44341394-E70CBE42-70FF-4B30-9DF6-046C8F8119DBQ44620640-3A88B2A2-2F28-4919-9017-10D8B4E1538DQ48189748-85796F10-54BF-42D8-B9C8-2B796A954052
P2860
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Bazedoxifene/conjugated estrog ...... eding in postmenopausal women.
@en
Bazedoxifene/conjugated estrogens
@nl
type
label
Bazedoxifene/conjugated estrog ...... eding in postmenopausal women.
@en
Bazedoxifene/conjugated estrogens
@nl
prefLabel
Bazedoxifene/conjugated estrog ...... eding in postmenopausal women.
@en
Bazedoxifene/conjugated estrogens
@nl
P2093
P1476
Bazedoxifene/conjugated estrog ...... eding in postmenopausal women.
@en
P2093
Bruce R Carr
David F Archer
James H Pickar
Sophie Olivier
Vivian Lewis
P304
P356
10.1016/J.FERTNSTERT.2009.05.093
P407
P577
2009-07-26T00:00:00Z